D053612Chemicals & DrugsD08.811.913.696.620.682.725.124D12.776.476.39321230.982144Janus Kinasesplugins:TwitterTwitterprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMedicine-Gastroenterology29988117Overstreet AM, LaTorre DL, Abernathy-Close L, Murphy SF, Rhee L, Boger AM, Adlaka KR, Iverson AM, Bakke DS, Weber CR, Boone DLMucosal immunologyThe JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis. Mucosal Immunol. 2018 09; 11(5):1454-1465.Mucosal Immunol2018-07-09T00:00:002018The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis.30333224Coffey GP, Feng J, Betz A, Pandey A, Birrell M, Leeds JM, Der K, Kadri S, Lu P, Segal J, Wang YL, Michelson G, Curnutte JT, Conley PBClinical cancer research : an official journal of the American Association for Cancer ResearchCerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies. Clin Cancer Res. 2019 02 15; 25(4):1174-1184.Clin Cancer Res2018-10-17T00:00:002018Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies.32041483Zhang B, Yang L, Zeng Z, Feng Y, Wang X, Wu X, Luo H, Zhang J, Zhang M, Pakvasa M, Wagstaff W, He F, Mao Y, Qin K, Ding H, Zhang Y, Niu C, Wu M, Zhao X, Wang H, Huang L, Shi D, Liu Q, Ni N, Fu K, Athiviraham A, Moriatis Wolf J, Lee MJ, Hynes K, Strelzow J, El Dafrawy M, Xia Y, He TCStem cells and developmentLeptin Potentiates BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells Through the Activation of JAK/STAT Signaling. Stem Cells Dev. 2020 04 15; 29(8):498-510.Stem Cells Dev2020-03-09T00:00:002020Leptin Potentiates BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells Through the Activation of JAK/STAT Signaling.32598086Wang J, Sun J, Hu J, Wang C, Prinz RA, Peng D, Liu X, Xu XFASEB journal : official publication of the Federation of American Societies for Experimental BiologyA77 1726, the active metabolite of the anti-rheumatoid arthritis drug leflunomide, inhibits influenza A virus replication in vitro and in vivo by inhibiting the activity of Janus kinases. FASEB J. 2020 08; 34(8):10132-10145.FASEB J2020-06-29T00:00:002020A77 1726, the active metabolite of the anti-rheumatoid arthritis drug leflunomide, inhibits influenza A virus replication in vitro and in vivo by inhibiting the activity of Janus kinases.Medicine-Hematology and OncologyOrthopedic Surgery and Rehabilitation MedicineAnandPatelAnand Patel41.7886000000000087.598699999999994043Patel, Anand0000-0002-0296-8686Assistant ProfessorTenzinChodenTenzin Choden41.7886000000000087.598699999999994219Choden, TenzinAssistant Professor0.7416470.029139621research area of0.7713520.11867819subject area forhttp://www.boneandcancer.orgLab homepagehttps://scholar.google.com/citations?user=YRifvyAAAAAJ&hl=enGoogle Scholaranand_88_patelUniversity of ChicagoRussell D.CohenRussell D. Cohen41.78927490000000-87.601250000000002354Cohen, Russell D.ProfessorOlatoyosiOdenikew21tDq8cEun5hHlsaUXv9Gq0+s+oOlatoyosi Odenike41.78927490000000-87.60125000000000399Odenike, OlatoyosiProfessorTong-ChuanHew2FhDoEXCuiXhHlsaUXv9Gq0+s+oTong-Chuan He41.78927490000000-87.60125000000000550He, Tong-ChuanAssociate Professortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professor27593379Fregoso Lomas M, De Vito S, Boisclair Lachance JF, Houde J, Nilson LACurrent biology : CBDetermination of EGFR Signaling Output by Opposing Gradients of BMP and JAK/STAT Activity. Curr Biol. 2016 10 10; 26(19):2572-2582.Curr Biol2016-09-01T00:00:002016Determination of EGFR Signaling Output by Opposing Gradients of BMP and JAK/STAT Activity.